You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR-ABL Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2022

      Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

      Active, not recruiting
      • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 2, 2022

      Concomitant Medications at CML Diagnosis

      Completed
      • Chronic Myeloid Leukemia
      • the prevalence of comorbid conditions
      • (no location specified)
      Sep 16, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
      • (no location specified)
      Jun 7, 2022

      Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Jena, Germany
        Universitätsklinikum Jena
      Jan 17, 2023

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

      Recruiting
      • Myeloproliferative Neoplasm
      • +2 more
      • Online Mindfulness Meditation
      • Internet-Based Webinars
      • San Francisco, California
        University of California San Francisco
      Aug 9, 2022

      B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • +2 more
      • Chicago, Illinois
      • +5 more
      Dec 27, 2021

      "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

      Not yet recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Sohag, Egypt
          Sohag University Hospital
        Sep 14, 2022

        3rd Line Therapy or More to Treat Adult CML- CP in Real World

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Oct 16, 2023

        Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Recombinant Interleukin-7
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 26, 2023

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

        Active, not recruiting
        • Acute Lymphoblastic Leukemia
        • +11 more
        • Health Promotion and Education
        • +3 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Jul 24, 2023

        Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

        Completed
        • Chronic Myeloid Leukemia
          • East Hanover, New Jersey
            Novartis
          Nov 20, 2023

          Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

          Not yet recruiting
          • Chronic Myelogenous Leukemia - Chronic Phase
          • APN and medical management
          • +3 more
          • Avignon, Provence-Alpes-Côte d'Azur, France
            Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
          Oct 13, 2023

          Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

          Completed
          • Leukemia
          • No Intervention
          • Cambridge, Massachusetts
            Takeda
          Feb 28, 2023

          Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +2 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 15, 2022

          Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

          Completed
          • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
          • Angers, France
          • +9 more
          Aug 17, 2022

          Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

          Active, not recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Jena, Germany
              University Hospital Jena
            Jan 17, 2023

            Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

            Completed
            • Leukemia, Myelogenous, Chronic
            • CTTQ Dasatinib tablet
            • Sprycel Dasatinib tablet
            • Changchun, Jilin, China
              Affiliated Hospital of Changchun University of Traditional Chine
            Dec 7, 2022